Table 2.
Patient ID | Gene | Exon | Genomic mutation | Predicted cDNA | Predicted protein | Protein domain | APOE genotype |
---|---|---|---|---|---|---|---|
506 | APP | 17 | g.275333C>T | c.2141C>T | p.Thr714Ile | TM-I | ε3/ε3 |
11323a | PSEN1 | 5 | g.25607A>G | c.404A>G | p.Asn135Ser | TM-II | - |
9018 | PSEN1 | 5 | g.25639A>C | c.436A>C | p.Met146Leu | TM-II | ε2/ε3 |
711 | PSEN1 | 7 | g.44636G>C | c.617G>C | p.Gly206Ala | TM-IV | ε4/ε4 |
15066 | PSEN1 | 7 | g.44636G>C | c.617G>C | p.Gly206Ala | TM-IV | ε2/ε3 |
11967 | PSEN1 | 7 | g.44636G>C | c.617G>C | p.Gly206Ala | TM-IV | ε3/ε3 |
10232 | PSEN1 | 7 | g.44672C>T | c.653C>T | p.Pro218Leuc c | TL-IV | ε3/ε3 |
15408 | PSEN1 | 7 | g.44733C>G | c.714C>G | p.Ile238Met | TM-V | ε3/ε4 |
14915 | PSEN2 | 5 | g.3661C>T | c.389C>T | p.Ser130Leu | HL-I | ε3/ε3 |
8120 | PSEN2 | 6 | g.6206A>G | c.520A>G | p.Met174Val | TM-III | ε4/ε4 |
15229 | PSEN2 | 6 | g.6234T>C | c.548T>C | p.Phe183Serc | C-Term | ε3/ε3 |
14330b | GRN | 6 | g.1407_1408delAG | c.592_593delAG | p.Arg198Glyfs19X | InterFB | ε3/ε4 |
15625 | MAPT | 13 | g.137465C>T | c.1216C>T | p.Arg406Trp | C-Term | ε3/ε3 |
9979 | C9ORF72 | Intronic | g.26724GGGGCC(3_23) | N/A | N/A | Non-coding | ε3/ε3 |
7391 | C9ORF72 | Intronic | g.26724GGGGCC(3_23) | N/A | N/A | Non-coding | ε3/ε3 |
Patient previously reported in Crook et al. (ref).
Patient previously reported in Finch et al. (ref).
Novel mutation.
APP, amyloid precursor protein, PSEN1, presenilin 1, PSEN2, presenilin 2, GRN, progranulin, MAPT, microtubule associated protein tau, C9ORF72, chromosome 9 open reading frame 72. N/A, not applicable, TM, transmembrane domain, HL, hydrophilic loop, C-Term, C-terminal domain, InterFB, linker region between granulins F and B.